LBF20406CV08: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR8004 |LipidMaps=LMFA03120004 |SysName=Methyl-4R- (5-cis,7-cis) -4-acetoxy-7- [ 2S-acetoxy-2- [cis-2-octenyl] -5-oxo...) |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR8004 | |LipidBank=XPR8004 | ||
|LipidMaps=LMFA03120004 | |LipidMaps=LMFA03120004 | ||
|SysName=Methyl-4R- (5- | |SysName=Methyl-4R- (cis-5,cis-7) -4-acetoxy-7- [ 2S-acetoxy-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid | ||
|Common Name=&&Clavulone IV&&Claviridenone-a&&Methyl-4R- (5Z,7Z) -4-acetoxy-7- [ 2S-acetoxy-2- | |Common Name=&&Clavulone IV&&Claviridenone-a&&Methyl-4R- (5Z,7Z) -4-acetoxy-7- [ 2S-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid&& | ||
|Optical=[ alpha ]_D -80.0°(CHCl_3 )[[Reference:Kikuchi_H:Tsukitani_Y:Iguchi_K:Yamada_Y:,Tennen Yuki Kagoubutsu Toronkai Koen Yoshishu 26th,1983,26,220|{{RelationTable/GetFirstAuthor|Reference:Kikuchi_H:Tsukitani_Y:Iguchi_K:Yamada_Y:,Tennen Yuki Kagoubutsu Toronkai Koen Yoshishu 26th,1983,26,220}}]] | |Optical=[ alpha ]_D -80.0°(CHCl_3 )[[Reference:Kikuchi_H:Tsukitani_Y:Iguchi_K:Yamada_Y:,Tennen Yuki Kagoubutsu Toronkai Koen Yoshishu 26th,1983,26,220|{{RelationTable/GetFirstAuthor|Reference:Kikuchi_H:Tsukitani_Y:Iguchi_K:Yamada_Y:,Tennen Yuki Kagoubutsu Toronkai Koen Yoshishu 26th,1983,26,220}}]] | ||
|Solubility=Clavulones are soluble in MeOH, EtOH, CHCl_3 , or hexane. | |Solubility=Clavulones are soluble in MeOH, EtOH, CHCl_3 , or hexane. |
Latest revision as of 06:00, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR8004 |
LipidMaps | LMFA03120004 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406CV08 |
Clavulone IV | |
---|---|
Structural Information | |
Methyl-4R- (cis-5,cis-7) -4-acetoxy-7- [ 2S-acetoxy-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid | |
| |
Formula | C25H34O7 |
Exact Mass | 446.230453442 |
Average Mass | 446.53326000000004 |
SMILES | O(C(C)=O)[C@@](C1=CC=C[C@@H](CCC(OC)=O)OC(C)=O)(CC=CCCCCC)C=CC1=O |
Physicochemical Information | |
[ α ]D -80.0°(CHCl3) KikuchiHet al. | |
Clavulones are soluble in MeOH, EtOH, CHCl3, or hexane. | |
Clavulones were isolated from Japanese soft coral, Stolonifer Clavularia viridis Quoy and Gaimard. Kikuchi_H et al. Kobayashi_M et al. Kikuchi_H et al. | |
Clavulones were synthesized from L-(+)-diethyl tartarate and D-mannitol as a natural form. Nagaoka_H et al.Other synthesis of clavulone. Klunder_AJH et al. Takemoto_M et al. Zhu_J et al. | |
The biosynthesis of clavulones is suggested to proceed from arachidonic acid via 8(R)-HEPETE and pre-clavulone A. Corey_EJ Corey_EJ et al. Corey_EJ et al. Corey_EJ et al. | |
Clavulones showed a significant anti-inflammatory effect at 30 mu g/ml by the fertile egg test. Kikuchi_H et al.Clavulone showed positive chronotropic action on the cultured myocardial cells. Honda_A et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | λ max(EtOH) 230 nm( ε 10600),295 nm( ε 9900) KikuchiHet al. |
IR Spectra | ν max(film)1730,1695,1640,and 1240cm-1 KikuchiHet al. |
NMR Spectra | 1H-NMR(270MHz,CDCl3) δ ppm0.88(3H,t,J=6.9Hz),2.03(3H,s),2.07(3H,s),2.36(2H,t,J=7.5Hz),2.65(1H,dd,J=7.3,14.2Hz),2.83(1H,dd,J=8,14.2Hz),3.68(3H,s),5.27(1H,m),5.52(1H,m),5.73(1H,t,J=10.6Hz),5.83(1H,m),6.39(1H,d,J=5.9Hz),7.02(1H,d,J=12.5Hz),7.49(1H,d,J=5.9Hz),7.61(1H,t,J=11.5Hz).(Yamada Yasuji)13C-NMR(67.8MHz,CDCl3) δ ppm14.0(q),21.1(q),21.6(q),22.5(t),27.4(t),29.1(t),29.6(t),29.8(t),31.5(t),36.1(t),51.7(q),68.1(d),85.0(s),121.5(d),126.0(d),127.9(d),134.8(d),136.5(d),136.6(d),137.0(s),156.7(d),169.9(s),170.1(s),172.9(s),194.2(s).(Yasuji Yamada) |
Other Spectra | CD λ ext(EtOH)( Δ ε )nm 245(+1.2),290(-1.4). KikuchiHet al. |
Chromatograms |
Reported Metabolites, References | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|